Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB

Nature

Volumn 430, Issue 7003, 2004, Pages 1034-1040

  Douma, Sirith ^a   Van Laar, Theo ^a   Zevenhoven, John ^a   Meuwissen, Ralph ^a   Van Garderen, Evert ^a   Peeper, Daniel S ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; BIOLOGICAL ORGANS; GENES; NEUROLOGY; PHYSIOLOGY; PROTEINS; TUMORS;

ANOIKIS; CELL-MATRIX INTERACTIONS; METASTASIS; NEUROTROPHIC RECEPTORS;

CELLS;

2 MORPHOLINO 8 PHENYLCHROMONE; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CASPASE; COMPLEMENTARY DNA; FIBRONECTIN; GREEN FLUORESCENT PROTEIN; LUCIFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN; RETROVIRUS VECTOR; TYROSINE KINASE RECEPTOR;

CANCER; MEDICINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOIKIS; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; BLOOD VESSEL; CELL AGGREGATION; CELL INFILTRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; INTESTINE EPITHELIUM CELL; LYMPH VESSEL; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE; PRIORITY JOURNAL; RAT; TUMOR GROWTH;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANOIKIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASES; CELL ADHESION; CELL LINE; CELL MOVEMENT; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSPLANTATION; EPITHELIAL CELLS; GENE LIBRARY; INTESTINES; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASMS; ONCOGENES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, TRKB; SURVIVAL RATE; TRANSDUCTION, GENETIC;

ANIMALIA; MUS MUSCULUS; UNIDENTIFIED RETROVIRUS;

EID: 4344627055     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02765     Document Type: Article

References (30)

1. Frisch, S. M. & Ruoslahti, E. Integrins and anoikis. Curr. Opin. Cell Biol. 9, 701-706 (1997).
2. Frisch, S. M. & Screaton, R. A. Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555-562 (2001).
3. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
4. Klein, R., Parada, L. F., Coulier, F. & Barbacid, M. trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J. 8, 3701-3709 (1989).
5. Huang, E. J. & Reichardt, L. F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609-642 (2003).
6. Shao, J., Sheng, H., DuBois, R. N. & Beauchamp, R. D. Oncogenic Ras-mediated cell growth arrest and apoptosis are associated with increased ubiquitin-dependent cyclin D1 degradation. J. Biol. Chem. 275, 22916-22924 (2000).
7. McFall, A. et al. Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase. Mol. Cell Biol. 21, 5488-5499 (2001).
8. Koh, E. Y., Chen, T. & Daley, G. Q. Novel retroviral vectors to facilitate expression screens in mammalian cells. Nucleic Acids Res. 30, e142 (2002).
9. Glass, D. J. et al. TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor. Cell 66, 405-413 (1991).
10. Jaboin, J., Hong, A., Kim, C. J. & Thiele, C. J. Cisplatin-induced cytotoxicity is blocked by brain-derived neurotrophic factor activation of TrkB signal transduction path in neuroblastoma. Cancer Lett. 193, 109-114 (2003).
11. Ho, R. et al. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res. 62, 6462-6466 (2002).
12. Klein, R. et al. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75, 113-122 (1993).
13. Banks, G. B. & Noakes, P. G. Elucidating the molecular mechanisms that underlie the target control of motoneuron death. Int. J. Dev. Biol. 46, 551-558 (2002).
14. Soppet, D. et al. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 65, 895-903 (1991).
15. Squinto, S. P. et al. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65, 885-893 (1991).
16. Ruoslahti, E. & Vaheri, A. Cell-to-cell contact and extracellular matrix. Curr. Opin. Cell Biol. 9, 605-607 (1997).
17. Reginato, M. J. et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nature Cell Biol. 5, 733-740 (2003).
18. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H. & Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16, 2783-2793 (1997).
19. Schmidt, M., Hovelmann, S. & Beckers, T. L. A novel form of constitutively active farnesylated Akt1 prevents mammary epithelial cells from anoikis and suppresses chemotherapy-induced apoptosis. Br. J. Cancer 87, 924-932 (2002).
20. Wendel, H. G. et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428, 332-337 (2004).
21. Vooijs, M., Jonkers, J., Lyons, S. & Berns, A. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumours in mice. Cancer Res. 62, 1862-1867 (2002).
22. Nakagawara, A., Azar, C. G., Scavarda, N. J. & Brodeur, G. M. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol. Cell Biol. 14, 759-767 (1994).
23. Aoyama, M. et al. Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett. 164, 51-60 (2001).
24. Eggert, A. et al. Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor. J. Clin. Oncol. 19, 689-696 (2001).
25. Brodeur, G. M. Neuroblastoma: biological insights into a clinical enigma. Nature Rev. Cancer 3, 203-216 (2003).
26. Bardelli, A. et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949 (2003).
27. Bernards, R. & Weinberg, R. A. A progression puzzle. Nature 418, 823 (2002).
28. Ruggeri, B. A., Miknyoczki, S. J., Singh, J. & Hudkins, R. L. Role of neurotrophin-trk interactions in oncology: the anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models. Curr. Med. Chem. 6, 845-857 (1999).
29. Peeper, D. S. et al. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nature Cell Biol. 4, 148-153 (2002).
30. Zamzami, N. et al. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183, 1533-1544 (1996).